The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment
ConditionCOVID
Trial statusRecruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorTanta University
About this trial
Efficacy of Ivermectin in larger doses in COVID-19 treatment
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with covid 19
Disqualifiers
Allergy or side effects to treatment
Trial design
Design model
Parallel
Treatments tested in this trial
Ivermectin
Drugivermectin
Treatment groups
300 Participants
are divided into 2 treatment groupsGroup A: IvermectinExperimental treatment 1 intervention
Group B: Standard treatmentNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Number of patients with improvement or died
The number of patients with improvement or death
Time frame
1 monthSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov